Table of Contents

Articles

• You have access

  Infusion of Gender-Dependent Plasma Growth Hormone Profiles Into Intact Rats: Effects of Subcutaneous, Intraperitoneal, and Intravenous Routes of Rat and Human Growth Hormone on Endogenous Circulating Growth Hormone Profiles and Expression of Sexually Dimorphic Hepatic Cyp Isoforms

  Nisar A. Pampori, Arun K. Agrawal and Bernard H. Shapiro

  Drug Metabolism and Disposition January 2001, 29 (1) 8-16;
• You have access

  Characterization of Cyp4a Induction in Rat Liver by Inflammatory Stimuli: Dependence on Sex, Strain, and Inflammation-Evoked Hypophagia

  Stephanie R. Mitchell, Marion B. Sewer, Sean S. Kardar and Edward T. Morgan

  Drug Metabolism and Disposition January 2001, 29 (1) 17-22;
• You have access

  A Method for the Simultaneous Evaluation of the Activities of Seven Major Human Drug-Metabolizing Cytochrome P450s Using an in Vitro Cocktail of Probe Substrates and Fast Gradient Liquid Chromatography Tandem Mass Spectrometry

  Elizabeth A. Dierks, Karen R. Stams, Heng-Keang Lim, Georgia Cornelius, Honglu Zhang and Simon E. Ball

  Drug Metabolism and Disposition January 2001, 29 (1) 23-29;
• You have access

  Application of Higher Throughput Screening (HTS) Inhibition Assays to Evaluate the Interaction of Antiparasitic Drugs with Cytochrome P450s

  Tashinga E. Bapiro, Ann-Charlotte Egnell, Julia A. Hasler and Collen M. Masimirembwa

  Drug Metabolism and Disposition January 2001, 29 (1) 30-35;
• You have access

  Role of CYP2C19 in Stereoselective Hydroxylation of Mephobarbital by Human Liver Microsomes

  Kaoru Kobayashi, Mari Kogo, Masayoshi Tani, Noriaki Shimada, Takashi Ishizaki, Satoshi Numazawa, Takemi Yoshida, Toshinori Yamamoto, Yukio Kuroiwa and Kan Chiba

  Drug Metabolism and Disposition January 2001, 29 (1) 36-40;
• You have access

  Interaction of Delavirdine with Human Liver Microsomal Cytochrome P450: Inhibition of CYP2C9, CYP2C19, and CYP2D6

  Richard L. Voorman, N. Ann Payne, Larry C. Wienkers, Michael J. Hauer and Phillip E. Sanders

  Drug Metabolism and Disposition January 2001, 29 (1) 41-47;
• You have access

  Use of Cloned and Expressed Human UDP-Glucuronosyltransferases for the Assessment of Human Drug Conjugation and Identification of Potential Drug Interactions

  Brian T. Ethell, Kevin Beaumont, David J. Rance and Brian Burchell

  Drug Metabolism and Disposition January 2001, 29 (1) 48-53;
• You have access

  The Transport of a Reversible Proton Pump Antagonist, 5,6-Dimethyl-2-(4-Fluorophenylamino)-4-(1-Methyl-1,2,3,4- Tetrahydroisoquinoline-2-yl) Pyrimidine Hydrochloride (YH1885), across Caco-2 Cell Monolayers

  Hong Li, Suk-Jae Chung, Dong-Chool Kim, Hyun-Soo Kim, Jong-Wook Lee and Chang-Koo Shim

  Drug Metabolism and Disposition January 2001, 29 (1) 54-59;
• You have access

  Metabolism of [¹⁴C]Omapatrilat, a Sulfhydryl-Containing Vasopeptidase Inhibitor in Humans

  Ramaswamy A. Iyer, James Mitroka, Bimal Malhotra, Samuel Bonacorsi, Stephen C. Waller, J. Kent Rinehart, Vikram A. Roongta and Kishin Kripalani

  Drug Metabolism and Disposition January 2001, 29 (1) 60-69;
• You have access

  Triazolam Substrate Inhibition: Evidence of Competition for Heme-Bound Reactive Oxygen Within the CYP3A4 Active Site

  Michael L. Schrag and Larry C. Wienkers

  Drug Metabolism and Disposition January 2001, 29 (1) 70-75;
• You have access

  Metabolism of Estradiol, Ethynylestradiol, and Moxestrol in Rat Uterus, Vagina, and Aorta: Influence of Sex Steroid Treatment

  Maarten J. Blom, Marjolein Groot Wassink, Helenius J. Kloosterboer, Antwan G. H. Ederveen, Jan G. D. Lambert and Henk J. Th. Goos

  Drug Metabolism and Disposition January 2001, 29 (1) 76-81;
• You have access

  Development of an in Vivo Preclinical Screen Model to Estimate Absorption and Bioavailability of Xenobiotics

  Keith W. Ward, Joel W. Proksch, Mark A. Levy and Brian R. Smith

  Drug Metabolism and Disposition January 2001, 29 (1) 82-88;